ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 178 filers reported holding ARENA PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 1.31 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $21,380,000 | -2.5% | 230,043 | -37.6% | 3.22% | +76.3% |
Q3 2021 | $21,938,000 | -0.3% | 368,399 | +14.2% | 1.82% | +2.5% |
Q2 2021 | $22,001,000 | -1.4% | 322,599 | +0.3% | 1.78% | +5.2% |
Q1 2021 | $22,320,000 | -9.2% | 321,659 | +0.5% | 1.69% | -2.4% |
Q4 2020 | $24,590,000 | -19.8% | 320,059 | -21.9% | 1.73% | -34.3% |
Q3 2020 | $30,657,000 | +34.2% | 409,905 | +13.0% | 2.64% | +25.7% |
Q2 2020 | $22,845,000 | +6781.0% | 362,900 | +4934.7% | 2.10% | +5891.4% |
Q3 2018 | $332,000 | – | 7,208 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Prosight Management, LP | 164,300 | $9,633,000 | 4.86% |
Atika Capital Management LLC | 230,000 | $13,485,000 | 2.65% |
DAFNA Capital Management LLC | 93,942 | $5,508,000 | 2.07% |
PFM Health Sciences, LP | 1,828,378 | $107,198,000 | 2.04% |
Perceptive Advisors | 1,380,171 | $80,919,000 | 1.86% |
Eversept Partners, LP | 73,501 | $4,309,364 | 1.21% |
Partner Investment Management, L.P. | 18,159 | $1,065,000 | 1.13% |
Rhenman & Partners Asset Management AB | 170,000 | $9,967,000 | 1.10% |
EMERALD ADVISERS, LLC | 425,510 | $24,948,000 | 1.00% |
EMERALD MUTUAL FUND ADVISERS TRUST | 388,418 | $22,773,000 | 0.90% |